These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 748005

  • 21. Differential stimulation of uterine cells by nafoxidine and clomiphene: relationship between nuclear estrogen receptors and type II estrogen binding sites and cellular growth.
    Markaverich BM, Upchurch S, McCormack SA, Glasser SR, Clark JH.
    Biol Reprod; 1981 Feb; 24(1):171-81. PubMed ID: 7470541
    [No Abstract] [Full Text] [Related]

  • 22. Dissociation of uterine eosinophilia and water imbibition from other estrogen-induced responses by nafoxidine pretreatment.
    Galand P, Tchernitchin N, Tchernitchin AN.
    Mol Cell Endocrinol; 1985 Oct; 42(3):227-33. PubMed ID: 2412910
    [Abstract] [Full Text] [Related]

  • 23. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
    Horwitz KB, Aiginger P, Kuttenn F, McGuire WL.
    Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178
    [No Abstract] [Full Text] [Related]

  • 24. Effects of an anti-estrogen on neural estradiol binding and on behaviors in female rats.
    Wade GN, Blaustein JD.
    Endocrinology; 1978 Jan; 102(1):245-51. PubMed ID: 743949
    [No Abstract] [Full Text] [Related]

  • 25. Different stability during incubation in vitro of the induced-protein (IP) response elicited in the rat uterus by treatment in vivo with oestradiol-17 beta or Nafoxidine [proceedings].
    Mairesse N, Galand P.
    Arch Int Physiol Biochim; 1977 Dec; 85(5):1003-4. PubMed ID: 79342
    [No Abstract] [Full Text] [Related]

  • 26. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [Abstract] [Full Text] [Related]

  • 27. Differential response of individual uterine cell types from immature rats treated with estradiol.
    McCormack SA, Glasser SR.
    Endocrinology; 1980 May; 106(5):1634-49. PubMed ID: 6153974
    [Abstract] [Full Text] [Related]

  • 28. Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth.
    Clark JH, Anderson JN, Peck EJ.
    Steroids; 1973 Nov; 22(5):707-18. PubMed ID: 4357534
    [No Abstract] [Full Text] [Related]

  • 29. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors.
    Attardi B, Happe HK.
    Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589
    [Abstract] [Full Text] [Related]

  • 30. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ, Jordan VC.
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [Abstract] [Full Text] [Related]

  • 31. Effect of neonatal exposure to the antioestrogens nafoxidine and CI-628 upon the development of the uterus in the prepubertal rat.
    Campbell PS, Satterfield PM.
    J Reprod Fertil; 1988 May; 83(1):225-31. PubMed ID: 3397940
    [Abstract] [Full Text] [Related]

  • 32. Time-course of the effects of nafoxidine and oestradiol on separate groups of responses in the uterus of the immature rat.
    Galand P, Tchernitchin N, Tchernitchin AN.
    J Steroid Biochem; 1984 Jul; 21(1):43-7. PubMed ID: 6748655
    [Abstract] [Full Text] [Related]

  • 33. [Comparative study of the behavior of an anti-estrogen and estradiol in uterine cells].
    Rochefort H, Capony F.
    C R Acad Hebd Seances Acad Sci D; 1973 Apr 09; 276(15):2321-4. PubMed ID: 4197649
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antiestrogens: effects of tamoxifen, nafoxidine, and CI-628 on sexual behavior, cytoplasmic receptors, and nuclear binding of estrogen.
    Etgen AM.
    Horm Behav; 1979 Oct 09; 13(2):97-112. PubMed ID: 399606
    [No Abstract] [Full Text] [Related]

  • 36. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
    Fanidi A, Courion-Guichardaz C, Fayard JM, Pageaux JF, Laugier C.
    Endocrinology; 1989 Sep 09; 125(3):1187-93. PubMed ID: 2547579
    [Abstract] [Full Text] [Related]

  • 37. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
    Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS.
    Endocrinology; 1984 Feb 09; 114(2):629-37. PubMed ID: 6690295
    [Abstract] [Full Text] [Related]

  • 38. Mechanism of action of estrogen agonists and antagonists.
    Clark JH, Hardin JW, McCormack SA.
    J Anim Sci; 1979 Feb 09; 49 Suppl 2():46-65. PubMed ID: 400777
    [Abstract] [Full Text] [Related]

  • 39. Nafoxidine-responsive uterine protein: further characterization and distinction from the "estrogen-induced" protein (IP).
    Mairesse N, Reiss N, Galand P, Kaye AM.
    Mol Cell Endocrinol; 1981 Oct 09; 24(1):53-63. PubMed ID: 6173271
    [Abstract] [Full Text] [Related]

  • 40. MER-25 and U-11, 100A, two antiestrogens with tissue-selective and incomplete estrogenic activity, on rat uterus.
    Ljungkvist I, Terenius L.
    Contraception; 1974 Oct 09; 10(4):395-404. PubMed ID: 4452241
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.